La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Small-molecule correctors of defective ΔF508-CFTR cellular processing identified by high-throughput screening

Identifieur interne : 000568 ( Ncbi/Curation ); précédent : 000567; suivant : 000569

Small-molecule correctors of defective ΔF508-CFTR cellular processing identified by high-throughput screening

Auteurs : Nicoletta Pedemonte [États-Unis, Italie] ; Gergely L. Lukacs [Canada] ; Kai Du [Canada] ; Emanuela Caci [Italie] ; Olga Zegarra-Moran [Italie] ; Luis J. V. Galietta [Italie] ; A. S. Verkman [États-Unis]

Source :

RBID : PMC:1190372

Abstract

The most common cause of cystic fibrosis (CF) is deletion of phenylalanine 508 (ΔF508) in the CF transmembrane conductance regulator (CFTR) chloride channel. The ΔF508 mutation produces defects in folding, stability, and channel gating. To identify small-molecule correctors of defective cellular processing, we assayed iodide flux in ΔF508-CFTR–transfected epithelial cells using a fluorescent halide indicator. Screening of 150,000 chemically diverse compounds and more than 1,500 analogs of active compounds yielded several classes of ΔF508-CFTR correctors (aminoarylthiazoles, quinazolinylaminopyrimidinones, and bisaminomethylbithiazoles) with micromolar potency that produced greater apical membrane chloride current than did low-temperature rescue. Correction was seen within 3–6 hours and persisted for more than 12 hours after washout. Functional correction was correlated with plasma membrane expression of complex-glycosylated ΔF508-CFTR protein. Biochemical studies suggested a mechanism of action involving improved ΔF508-CFTR folding at the ER and stability at the cell surface. The bisaminomethylbithiazoles corrected ΔF508-CFTR in ΔF508/ΔF508 human bronchial epithelia but did not correct a different temperature-sensitive CFTR mutant (P574H-CFTR) or a dopamine receptor mutant. Small-molecule correctors may be useful in the treatment of CF caused by the ΔF508 mutation.


Url:
DOI: 10.1172/JCI24898
PubMed: 16127463
PubMed Central: 1190372

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:1190372

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Small-molecule correctors of defective ΔF508-CFTR cellular processing identified by high-throughput screening</title>
<author>
<name sortKey="Pedemonte, Nicoletta" sort="Pedemonte, Nicoletta" uniqKey="Pedemonte N" first="Nicoletta" last="Pedemonte">Nicoletta Pedemonte</name>
<affiliation wicri:level="2">
<nlm:aff id="N0x96f1758.0x9c2e670">Departments of Medicine and Physiology, UCSF, San Francisco, California, USA.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Departments of Medicine and Physiology, UCSF, San Francisco, California</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="N0x96f1758.0x9c2e670">Laboratorio di Genetica Molecolare, Istituto Giannina Gaslini, Genova, Italy.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Italie</country>
<wicri:regionArea>Laboratorio di Genetica Molecolare, Istituto Giannina Gaslini, Genova</wicri:regionArea>
<wicri:noRegion>Genova</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lukacs, Gergely L" sort="Lukacs, Gergely L" uniqKey="Lukacs G" first="Gergely L." last="Lukacs">Gergely L. Lukacs</name>
<affiliation wicri:level="4">
<nlm:aff id="N0x96f1758.0x9c2e670">Program in Cell and Lung Biology, Hospital for Sick Children Research Institute, and University of Toronto, Toronto, Ontario, Canada.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Canada</country>
<wicri:regionArea>Program in Cell and Lung Biology, Hospital for Sick Children Research Institute, and University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Du, Kai" sort="Du, Kai" uniqKey="Du K" first="Kai" last="Du">Kai Du</name>
<affiliation wicri:level="4">
<nlm:aff id="N0x96f1758.0x9c2e670">Program in Cell and Lung Biology, Hospital for Sick Children Research Institute, and University of Toronto, Toronto, Ontario, Canada.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Canada</country>
<wicri:regionArea>Program in Cell and Lung Biology, Hospital for Sick Children Research Institute, and University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Caci, Emanuela" sort="Caci, Emanuela" uniqKey="Caci E" first="Emanuela" last="Caci">Emanuela Caci</name>
<affiliation wicri:level="1">
<nlm:aff id="N0x96f1758.0x9c2e670">Laboratorio di Genetica Molecolare, Istituto Giannina Gaslini, Genova, Italy.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Italie</country>
<wicri:regionArea>Laboratorio di Genetica Molecolare, Istituto Giannina Gaslini, Genova</wicri:regionArea>
<wicri:noRegion>Genova</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zegarra Moran, Olga" sort="Zegarra Moran, Olga" uniqKey="Zegarra Moran O" first="Olga" last="Zegarra-Moran">Olga Zegarra-Moran</name>
<affiliation wicri:level="1">
<nlm:aff id="N0x96f1758.0x9c2e670">Laboratorio di Genetica Molecolare, Istituto Giannina Gaslini, Genova, Italy.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Italie</country>
<wicri:regionArea>Laboratorio di Genetica Molecolare, Istituto Giannina Gaslini, Genova</wicri:regionArea>
<wicri:noRegion>Genova</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Galietta, Luis J V" sort="Galietta, Luis J V" uniqKey="Galietta L" first="Luis J. V." last="Galietta">Luis J. V. Galietta</name>
<affiliation wicri:level="1">
<nlm:aff id="N0x96f1758.0x9c2e670">Laboratorio di Genetica Molecolare, Istituto Giannina Gaslini, Genova, Italy.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Italie</country>
<wicri:regionArea>Laboratorio di Genetica Molecolare, Istituto Giannina Gaslini, Genova</wicri:regionArea>
<wicri:noRegion>Genova</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Verkman, A S" sort="Verkman, A S" uniqKey="Verkman A" first="A. S." last="Verkman">A. S. Verkman</name>
<affiliation wicri:level="2">
<nlm:aff id="N0x96f1758.0x9c2e670">Departments of Medicine and Physiology, UCSF, San Francisco, California, USA.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Departments of Medicine and Physiology, UCSF, San Francisco, California</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">16127463</idno>
<idno type="pmc">1190372</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1190372</idno>
<idno type="RBID">PMC:1190372</idno>
<idno type="doi">10.1172/JCI24898</idno>
<date when="2005">2005</date>
<idno type="wicri:Area/Pmc/Corpus">000217</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000217</idno>
<idno type="wicri:Area/Pmc/Curation">000217</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000217</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000C38</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000C38</idno>
<idno type="wicri:Area/Ncbi/Merge">000568</idno>
<idno type="wicri:Area/Ncbi/Curation">000568</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Small-molecule correctors of defective ΔF508-CFTR cellular processing identified by high-throughput screening</title>
<author>
<name sortKey="Pedemonte, Nicoletta" sort="Pedemonte, Nicoletta" uniqKey="Pedemonte N" first="Nicoletta" last="Pedemonte">Nicoletta Pedemonte</name>
<affiliation wicri:level="2">
<nlm:aff id="N0x96f1758.0x9c2e670">Departments of Medicine and Physiology, UCSF, San Francisco, California, USA.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Departments of Medicine and Physiology, UCSF, San Francisco, California</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="N0x96f1758.0x9c2e670">Laboratorio di Genetica Molecolare, Istituto Giannina Gaslini, Genova, Italy.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Italie</country>
<wicri:regionArea>Laboratorio di Genetica Molecolare, Istituto Giannina Gaslini, Genova</wicri:regionArea>
<wicri:noRegion>Genova</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lukacs, Gergely L" sort="Lukacs, Gergely L" uniqKey="Lukacs G" first="Gergely L." last="Lukacs">Gergely L. Lukacs</name>
<affiliation wicri:level="4">
<nlm:aff id="N0x96f1758.0x9c2e670">Program in Cell and Lung Biology, Hospital for Sick Children Research Institute, and University of Toronto, Toronto, Ontario, Canada.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Canada</country>
<wicri:regionArea>Program in Cell and Lung Biology, Hospital for Sick Children Research Institute, and University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Du, Kai" sort="Du, Kai" uniqKey="Du K" first="Kai" last="Du">Kai Du</name>
<affiliation wicri:level="4">
<nlm:aff id="N0x96f1758.0x9c2e670">Program in Cell and Lung Biology, Hospital for Sick Children Research Institute, and University of Toronto, Toronto, Ontario, Canada.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Canada</country>
<wicri:regionArea>Program in Cell and Lung Biology, Hospital for Sick Children Research Institute, and University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Caci, Emanuela" sort="Caci, Emanuela" uniqKey="Caci E" first="Emanuela" last="Caci">Emanuela Caci</name>
<affiliation wicri:level="1">
<nlm:aff id="N0x96f1758.0x9c2e670">Laboratorio di Genetica Molecolare, Istituto Giannina Gaslini, Genova, Italy.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Italie</country>
<wicri:regionArea>Laboratorio di Genetica Molecolare, Istituto Giannina Gaslini, Genova</wicri:regionArea>
<wicri:noRegion>Genova</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zegarra Moran, Olga" sort="Zegarra Moran, Olga" uniqKey="Zegarra Moran O" first="Olga" last="Zegarra-Moran">Olga Zegarra-Moran</name>
<affiliation wicri:level="1">
<nlm:aff id="N0x96f1758.0x9c2e670">Laboratorio di Genetica Molecolare, Istituto Giannina Gaslini, Genova, Italy.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Italie</country>
<wicri:regionArea>Laboratorio di Genetica Molecolare, Istituto Giannina Gaslini, Genova</wicri:regionArea>
<wicri:noRegion>Genova</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Galietta, Luis J V" sort="Galietta, Luis J V" uniqKey="Galietta L" first="Luis J. V." last="Galietta">Luis J. V. Galietta</name>
<affiliation wicri:level="1">
<nlm:aff id="N0x96f1758.0x9c2e670">Laboratorio di Genetica Molecolare, Istituto Giannina Gaslini, Genova, Italy.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Italie</country>
<wicri:regionArea>Laboratorio di Genetica Molecolare, Istituto Giannina Gaslini, Genova</wicri:regionArea>
<wicri:noRegion>Genova</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Verkman, A S" sort="Verkman, A S" uniqKey="Verkman A" first="A. S." last="Verkman">A. S. Verkman</name>
<affiliation wicri:level="2">
<nlm:aff id="N0x96f1758.0x9c2e670">Departments of Medicine and Physiology, UCSF, San Francisco, California, USA.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Departments of Medicine and Physiology, UCSF, San Francisco, California</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of Clinical Investigation</title>
<idno type="ISSN">0021-9738</idno>
<imprint>
<date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>The most common cause of cystic fibrosis (CF) is deletion of phenylalanine 508 (ΔF508) in the CF transmembrane conductance regulator (CFTR) chloride channel. The ΔF508 mutation produces defects in folding, stability, and channel gating. To identify small-molecule correctors of defective cellular processing, we assayed iodide flux in ΔF508-CFTR–transfected epithelial cells using a fluorescent halide indicator. Screening of 150,000 chemically diverse compounds and more than 1,500 analogs of active compounds yielded several classes of ΔF508-CFTR correctors (aminoarylthiazoles, quinazolinylaminopyrimidinones, and bisaminomethylbithiazoles) with micromolar potency that produced greater apical membrane chloride current than did low-temperature rescue. Correction was seen within 3–6 hours and persisted for more than 12 hours after washout. Functional correction was correlated with plasma membrane expression of complex-glycosylated ΔF508-CFTR protein. Biochemical studies suggested a mechanism of action involving improved ΔF508-CFTR folding at the ER and stability at the cell surface. The bisaminomethylbithiazoles corrected ΔF508-CFTR in ΔF508/ΔF508 human bronchial epithelia but did not correct a different temperature-sensitive CFTR mutant (P574H-CFTR) or a dopamine receptor mutant. Small-molecule correctors may be useful in the treatment of CF caused by the ΔF508 mutation.</p>
</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000568 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000568 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     PMC:1190372
   |texte=   Small-molecule correctors of defective 
ΔF508-CFTR cellular processing identified 
by high-throughput screening
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:16127463" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022